MCID: PLM016
MIFTS: 39

Pleomorphic Carcinoma malady

Category: Cancer diseases

Aliases & Classifications for Pleomorphic Carcinoma

About this section

Aliases & Descriptions for Pleomorphic Carcinoma:

Name: Pleomorphic Carcinoma 11 13 66

Classifications:



External Ids:

Disease Ontology11 DOID:5662
SNOMED-CT60 16741004
NCIt43 C4094

Summaries for Pleomorphic Carcinoma

About this section
Disease Ontology:11 A carcinoma that is consisting of spindle or giant cells (or both) combined with squamous cell carcinoma, adenocarcinoma, or large-cell carcinoma.

MalaCards based summary: Pleomorphic Carcinoma is related to pseudounicornuate uterus and trachea adenoid cystic carcinoma. An important gene associated with Pleomorphic Carcinoma is EGFR (Epidermal Growth Factor Receptor), and among its related pathways are Gastric cancer network 2 and Bladder cancer. Affiliated tissues include lung, pancreas and breast, and related mouse phenotypes are liver/biliary system and adipose tissue.

Related Diseases for Pleomorphic Carcinoma

About this section

Diseases related to Pleomorphic Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 144)
idRelated DiseaseScoreTop Affiliating Genes
1pseudounicornuate uterus10.6EGFR, NKX2-1
2trachea adenoid cystic carcinoma10.6EGFR, NKX2-1
3peptic ulcer disease10.6EGFR, TP53
4tamoxifen-related endometrial lesion10.6EGFR, TP53
5yolk sac tumor of central nervous system10.6EGFR, TP53
6cerebellum cancer10.6EGFR, TP53
7uterine corpus epithelioid leiomyosarcoma10.6EGFR, TP53
8external ear disease10.5NKX2-1, TP53
9herpes simplex10.5EGFR, TP53
10ovarian brenner tumor10.5NKX2-1, TP53
11adult teratoma10.5NKX2-1, TP53
12stampe sorensen syndrome10.5EGFR, TP53
13early myoclonic encephalopathy10.5EGFR, TP53
14bone remodeling disease10.5NKX2-1, TP53
15cervical benign neoplasm10.5EGFR, TP53
16distal monosomy 9p10.5EGFR, TP53
17lipomatosis10.5EGFR, TP53
18mast-cell sarcoma10.5KRT8, NKX2-1
19camera marugo cohen syndrome10.5KRT8, TP53
20mesenchymoma10.5NKX2-1, TP53
21bladder colonic type adenocarcinoma10.5EGFR, KRT14
22secondary syphilis10.5EGFR, KRT8
23submucosal invasive colon adenocarcinoma10.5EGFR, NKX2-1
24gastric squamous cell carcinoma10.5EGFR, KRT14
25actinic keratosis10.5EGFR, TP53
26grade iii astrocytoma10.5EGFR, TP53
27mantle cell lymphoma10.4EGFR, TP53
28integumentary system cancer10.4EGFR, TP53
29extrahepatic bile duct adenocarcinoma10.4KRT8, TP53
30pancreatic cancer10.4KRT8, TP53
31pleomorphic carcinoma10.4EGFR, KRT14
32fallopian tube mucinous adenocarcinoma10.4EGFR, TP53
33eccrine papillary adenoma10.4KRT14, TP53
34short stature-deafness-neutrophil dysfunction-dysmorphism syndrome10.4KRT18, KRT8
35dental caries10.4EGFR, TP53
36hypotrichosis 1310.4KRT18, KRT8
37propriospinal myoclonus10.4KRT18, KRT8
38bartholin's gland adenoid cystic carcinoma10.4EGFR, KIT
39anterior horn cell disease10.4KRT18, KRT8
40breast papillary carcinoma10.4EGFR, KIT
41milker's nodule10.4EGFR, TP53
42brain stem ependymoma10.3KRT18, KRT8
43sphenoidal sinus cancer10.3KIT, NKX2-1
44ovarian wilms' cancer10.3EGFR, TP53
45localized pulmonary fibrosis10.3KIT, NKX2-1
46rhinitis10.3KRT18, KRT8
47comedo carcinoma10.3KRT18, KRT8
48male reproductive organ cancer10.3KRT14, KRT8
49oral lichen planus10.3EGFR, TP53
50ureter squamous cell carcinoma10.3KIT, TP53

Graphical network of the top 20 diseases related to Pleomorphic Carcinoma:



Diseases related to pleomorphic carcinoma

Symptoms for Pleomorphic Carcinoma

About this section

Drugs & Therapeutics for Pleomorphic Carcinoma

About this section

Drugs for Pleomorphic Carcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DoxilApproved June 1999Phase 2167631703
Synonyms:
Dox-SL
Doxil
 
Evacet
LipoDox
Pegylated Liposomal Doxorubicin Hydrochloride
liposomal doxorubicin
2
CarboplatinPhase 2194241575-94-410339178, 498142, 38904
Synonyms:
(SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum
/h1-3H2,(H,7,8)(H,9,10)
/q
1,1-Cyclobutanedicarboxylate diammine platinum (II)
1,1-Cyclobutanedicarboxylate diammine platinum(II)
2*-1
2*1H2
41575-94-4
70903-55-8
AC-1457
AC1L8I6U
Ambap41575-94-4
BSPBio_003145
C 2538
C2043
C2538_SIGMA
C6H10N2O4Pt
CBDCA
CCRIS 3404
CHEBI:31355
CHEMBL1351
CHEMBL288376
CID10339178
CID2567
CID38904
CID426756
CID498142
CID5352133
CID6398587
CID6603770
Carbopaltin
Carboplatin
Carboplatin (JAN/USP/INN)
Carboplatin (USAN)
Carboplatin [USAN:INN:BAN:JAN]
Carboplatine
Carboplatine [French]
Carboplatino
Carboplatino [Spanish]
Carboplatinum
Carboplatinum [Latin]
Cbdca
Cyclobutane-1,1-dicarboxylate
D01363
DB00958
Diammine(1,1-cyclobutanedicarboxylato)platinum (II)
Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum
Diammine-1,1-cyclobutane dicarboxylate platinum II
DivK1c_000892
EINECS 255-446-0
EU-0100230
Ercar
HMS1921J16
HMS2090M05
HMS2092B22
HMS502M14
HSDB 6957
I14-2390
IDI1_000892
IUPAC: Azane
InChI=1/C6H8O4.2H2N.Pt/c7-4(8)6(5(9)10)2-1-3-6
 
JM 8
JM-8
KBio1_000892
KBio2_002009
KBio2_004577
KBio2_007145
KBio3_002645
KBioGR_000713
KBioSS_002009
LS-117689
Lopac-C-2538
Lopac0_000230
MolPort-003-665-501
MolPort-003-845-609
NCGC00015223-01
NCGC00093695-01
NCGC00094961-01
NCGC00094961-02
NCGC00094961-03
NCGC00162099-01
NCGC00162099-02
NCGC00167800-01
NCGC00178242-01
NINDS_000892
NSC 201345
NSC 241240
NSC-241240
NSC201345
NSC241240
Paraplatin
Paraplatin (TN)
Paraplatin, Carboplatin
Paraplatin-AQ
Platinum(+2) Cation
Platinum(II), (1, 1-cyclobutanedicar
Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2)
Platinum, {diammine[1,1-cyclobut
S1215_Selleck
SPBio_000716
SPECTRUM1502106
Spectrum2_000898
Spectrum3_001503
Spectrum4_000337
Spectrum5_001094
Spectrum_001529
UNII-BG3F62OND5
azanide
carboplatin
cis -Diammine[1,1-cyclobutane-dicarboxylato] platinum
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II)
cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(ii)
cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II)
cis-Diammine(1,1-cyclobutanedicarboxylato) platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum
cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II)
cis-Diammine(cyclobutanedicarboxylato)platinum II
cyclobutane-1,1-dicarboxylic acid
diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum
nchembio.573-comp10
nchembio773-comp2
nchembio873-comp3
platinum(2+)
3
DoxorubicinPhase 2167623214-92-831703
Synonyms:
(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside
(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione
111266-55-8
14-Hydroxydaunomycin
14-Hydroxydaunorubicine
14-hydroxydaunomycin
14-hydroxydaunorubicine
23214-92-8
23257-17-2
24385-08-8
25311-50-6
25316-40-9
25316-40-9 (hydrochloride)
29042-30-6
AC1L1M5T
AC1Q29OJ
ADM
ADR
Adriablastin
Adriacin (hydrochloride salt)
Adriamycin
Adriamycin PFS
Adriamycin PFS (hydrochloride salt)
Adriamycin RDF
Adriamycin RDF (hydrochloride salt)
Adriamycin Semiquinone
Adriamycin semiquinone
Adriblas tina
Adriblastin
Adriblastina
Adriblastina (TN)
Adriblastina (hydrochloride salt)
Aerosolized Doxorubicin
BPBio1_000502
BRD-K92093830-003-04-3
BSPBio_000456
BSPBio_001031
C01661
C27H29NO11
CCRIS 739
CHEBI:28748
CHEMBL179
CID31703
Caelyx
Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74
Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120
D03899
DB00997
DM2
DOX-SL
Doxil
Doxo
Doxorubicin
Doxorubicin (USAN/INN)
Doxorubicin HCl
 
Doxorubicin Hydrochloride
Doxorubicin [USAN:INN:BAN]
Doxorubicin citrate
Doxorubicin hydrochloride (hydrochloride salt)
Doxorubicin-P4/D10
Doxorubicin-P4/D10 conjugate
Doxorubicin-hLL1
Doxorubicin-hLL1 conjugate
Doxorubicina
Doxorubicina [INN-Spanish]
Doxorubicine
Doxorubicine [INN-French]
Doxorubicinum
Doxorubicinum [INN-Latin]
EINECS 245-495-6
FI 106
Farmablastina (hydrochloride salt)
HMS2089H06
HSDB 3070
Hydroxydaunomycin hydrochlor ide (hydrochloride salt)
Hydroxydaunomycin hydrochloride (hydrochloride salt)
Hydroxydaunorubicin
Hydroxydaunorubicin hydrochloride (hydrochloride salt)
JT9100000
LMPK13050001
LS-1029
LS-165655
MLS000759533
Myocet
NCI-C01514
NChemBio.2007.10-comp13
NDC 38242-874
NIOSH/JT9100000
NSC 123127
Prestwick0_000438
Prestwick1_000438
Prestwick2_000438
Prestwick3_000438
Probes1_000151
Probes2_000129
RDF Rubex
Resmycin
Rubex
Rubex (hydrochloride salt)
SMP1_000106
SPBio_002395
TLC D-99
ThermoDox
Triferric doxorubicin
UNII-80168379AG
adiblastine (hydrochloride salt)
adr iablatina (hydrochloride salt)
adriablastine (hydrochloride salt)
adriablatina (hydrochloride salt)
adriblatina (hydrochloride salt)
doxorubicin
nchembio809-comp5
4
PaclitaxelPhase 2269133069-62-436314
Synonyms:
(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester
12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
157069-30-2
33069-62-4
5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine
7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.
7-Epi-Paclitaxel
7-Epi-Taxol
7-Epipaclitaxel
7-Epitaxol
7-epi-Paclitaxel
7-epi-Taxol
AB00513812
ABI 007
ABI-007
ABI007
AC-675
AC1L1IOG
AC1L1VJI
AC1L9AVF
ACon1_002231
ANX-513
Abraxane
Abraxane (TN)
Abraxane I.V. Suspension
Abraxis BioScience brand of albumin-bound paclitaxel
Ambotz33069-62-4
Anzatax
Asotax
BIDD:PXR0046
BMS 181339-01
BMS-181339
BMS-181339-01
BPBio1_000320
BRD-A23723433-001-01-2
BRD-A28746609-001-04-0
BRD-K62008436-001-03-1
BSPBio_000290
BSPBio_001152
BSPBio_002614
Bio-0076
Bio1_000362
Bio1_000851
Bio1_001340
Bio2_000416
Bio2_000896
Bristaxol
C07394
C466458
C47H51NO14
CCRIS 8143
CHEBI:103439
CHEBI:45863
CHEMBL100910
CHEMBL418410
CHEMBL48
CID36314
CID441276
CID4666
CID6713921
CID6915727
CPD-8718
Capxol
D00491
DB01229
DHP-107
DHP-208
DRG-0190
DTS-301
DivK1c_000441
EU-0101201
Ebetaxel
EmPAC
Epitaxol
Genaxol
Genetaxyl
Genexol
Genexol-PM
HMS1362J13
HMS1568O12
HMS1792J13
HMS1922K08
HMS1990J13
HMS2090D07
HMS2093K15
HMS501G03
HSDB 6839
I06-0014
IDI1_000441
IDI1_002171
Intaxel
KBio1_000441
KBio2_000492
KBio2_002016
KBio2_002509
KBio2_003060
KBio2_004584
KBio2_005077
KBio2_005628
KBio2_007152
KBio2_007645
KBio3_000903
KBio3_000904
KBio3_001834
KBio3_002987
KBioGR_000492
KBioGR_001893
 
KBioGR_002509
KBioSS_000492
KBioSS_002016
KBioSS_002517
LMPR0104390001
LS-31070
LipoPac
Lopac0_001201
MBT 0206
MEGxp0_001940
MLS000863266
MLS001077297
MLS002154218
MLS002172439
MLS002695976
MPI-5018
Micellar Paclitaxel
Mitotax
MolPort-001-742-627
MolPort-003-665-783
MolPort-003-932-365
NCGC00024995-02
NCGC00024995-03
NCGC00024995-04
NCGC00024995-05
NCGC00024995-06
NCGC00024995-07
NCGC00164367-01
NCGC00164367-02
NCGC00164367-03
NCI60_000601
NINDS_000441
NK 105
NP-010981
NSC 125973
NSC-125973
NSC125973
NSC358882
Nanotaxel
Neuro_000060
Nova-12005
OAS-PAC-100
OncoGel
Onxal
Onxol
Onxol, Taxol, Nov-Onxol, Paclitaxel
P1632
Paclical
Pacligel
Paclitaxel
Paclitaxel (JAN/USP)
Paclitaxel (JAN/USP/INN)
Paclitaxel (Taxol)
Paclitaxel [USAN:INN:BAN]
Paxceed
Paxene
Paxoral
Plaxicel
Praxel
Prestwick0_000155
Prestwick1_000155
Prestwick2_000155
Prestwick3_000155
Probes2_000350
QW 8184
S-8184 Paclitaxel Injectable Emulsion
S1150_Selleck
SDCCGMLS-0066823.P001
SDP-013
SMP1_000228
SMR000394086
SMR000857385
SPBio_000943
SPBio_002229
SPECTRUM1503908
ST50306996
Spectrum2_000872
Spectrum3_001057
Spectrum4_001197
Spectrum5_001491
Spectrum_001536
T 7402
T1912_SIGMA
T7191_SIGMA
T7402_SIGMA
TA1
TAXOL (TN)
TAXOL, 10-EPI,
TXL
TaxAlbin
Taxol
Taxol A
Taxol Konzentrat
Taxol.RTM. (Registered Trademark)
UNII-P88XT4IS4D
UPCMLD-DP108:001
UPCMLD-DP108:002
Vascular Wrap
Xorane
Yewtaxan
abi-007
albumin-bound paclitaxel
cMAP_000068
nab-paclitaxel
nchembio.188-comp1
nchembio.2007.34-comp9
nchembio.215-comp9
nchembio853-comp6
paclitaxel
weekly paclitaxel

Interventional clinical trials:

idNameStatusNCT IDPhase
1Combination Chemotherapy Consisting of Pegylated Liposomal Doxorubicin and Carboplatin in Malignant Gynecologic TumoursCompletedNCT00189410Phase 2
2Carboplatin and Paclitaxel in Elderly Women With Newly Diagnosed Ovarian, Peritoneal, or Fallopian CancerTerminatedNCT00322881Phase 2
3Trial of Radiotherapy and Panitumumab in Salivary Gland MalignanciesWithdrawnNCT00984217Phase 2
4Study of Imaging Characteristics OCT of Skin Lesions Requiring Biopsy / ResectionNot yet recruitingNCT02851693

Search NIH Clinical Center for Pleomorphic Carcinoma

Genetic Tests for Pleomorphic Carcinoma

About this section

Anatomical Context for Pleomorphic Carcinoma

About this section

MalaCards organs/tissues related to Pleomorphic Carcinoma:

34
Lung, Pancreas, Breast, Skin, Salivary gland, Thyroid, Colon

Animal Models for Pleomorphic Carcinoma or affiliated genes

About this section

MGI Mouse Phenotypes related to Pleomorphic Carcinoma:

39 (show all 19)
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053708.6EGFR, KIT, KRT18, KRT8, TP53
2MP:00053758.6EGFR, KRT14, TP53, ZEB1
3MP:00053778.3EGFR, KIT, KRT14, TP53, ZEB1
4MP:00107718.3EGFR, KIT, KRT14, TP53, ZEB1
5MP:00011868.2EGFR, KIT, KRT14, TP53, ZEB1
6MP:00053828.2EGFR, KIT, KRT14, TP53, ZEB1
7MP:00053887.7EGFR, KIT, KRT14, NKX2-1, TP53, ZEB1
8MP:00053877.7EGFR, KIT, KRT14, KRT8, TP53, ZEB1
9MP:00020067.7EGFR, KIT, KRT14, NKX2-1, TP53, ZEB1
10MP:00053917.7EGFR, KIT, KRT14, TP53, ZEB1
11MP:00053807.6EGFR, KIT, KRT18, KRT8, TP53, ZEB1
12MP:00053977.6EGFR, KIT, KRT14, KRT8, TP53, ZEB1
13MP:00053857.5EGFR, KIT, KRT8, NKX2-1, TP53, ZEB1
14MP:00053797.4EGFR, KIT, KRT14, NKX2-1, TP53, ZEB1
15MP:00053897.3EGFR, KIT, KRT14, KRT8, NKX2-1, TP53
16MP:00053817.1EGFR, KIT, KRT14, KRT8, NKX2-1, TP53
17MP:00053766.9EGFR, KIT, KRT14, KRT8, NKX2-1, TP53
18MP:00107686.5EGFR, KIT, KRT14, KRT18, KRT8, NKX2-1
19MP:00053786.1EGFR, KIT, KRT14, KRT18, KRT8, NKX2-1

Publications for Pleomorphic Carcinoma

About this section

Articles related to Pleomorphic Carcinoma:

(show top 50)    (show all 115)
idTitleAuthorsYear
1
Pemetrexed and bevacizumab-containing chemotherapy for pleomorphic carcinoma of the lung. (27073676)
2016
2
"Pseudoprogression" of Pulmonary Pleomorphic Carcinoma during Nivolumab Therapy. (27189927)
2016
3
Programmed death-1 ligand 1 and 2 are highly expressed in pleomorphic carcinomas of the lung: Comparison of sarcomatous and carcinomatous areas. (26329973)
2015
4
Anaplastic Lymphoma Kinase (ALK) Rearrangement-positive Lung Cancer with Transformation to Pleomorphic Carcinoma. (26568007)
2015
5
Response to Crizotinib and Clinical Outcome in ALK-Rearranged Pulmonary Pleomorphic Carcinoma. (25898961)
2015
6
Successful treatment of two consecutive cases of pulmonary pleomorphic carcinoma with platinum chemotherapy. (26722286)
2015
7
Clinicoradiological outcomes of 33 cases of surgically resected pulmonary pleomorphic carcinoma: correlation with prognostic indicators. (25994197)
2015
8
A pleomorphic carcinoma of the lung producing multiple cytokines and forming a rapidly progressive mass-like opacity. (25123545)
2014
9
Bevacizumab for critical brain metastases in a patient with pulmonary pleomorphic carcinoma. (25130117)
2014
10
A case of synchronous double primary lung cancer presenting with pleomorphic carcinoma and adenocarcinoma. (25553415)
2014
11
Pulmonary pleomorphic carcinoma with multiple metastases to the right posterior knee complicated by paraneoplastic hypercalcemia. (24396467)
2014
12
Pleomorphic carcinoma of breast: a case report and review of literature. (25197400)
2014
13
Pulmonary pleomorphic carcinoma detected as a result of pneumothorax and the subsequent occurrence of multiple cystic metastases. (25214846)
2014
14
Urinary bladder urothelial carcinoma with expression of KIT and PDGFRA and showing diverse differentiations into plasmacytoid, clear cell, acantholytic, nested, and spindle variants, and into adenocarcinoma, signet-ring cell carcinoma, small cell carcinoma, large cell carcinoma, and pleomorphic carcinoma. (23696935)
2013
15
Pleomorphic carcinoma of the breast associated with cyst formation: a unique surgical case focusing on cytological and immunohistochemical findings. Cystic breast PC. (23651662)
2013
16
Resected pleomorphic carcinoma of the gallbladder. (23341796)
2012
17
Clinicopathological characteristics of surgically resected pulmonary pleomorphic carcinoma. (22228848)
2012
18
Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: report of a case. (21626334)
2011
19
Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy. (21626008)
2011
20
Two consecutive cases of platinum-refractory pulmonary pleomorphic carcinoma that showed dramatic responses to MAID (mesna, doxorubicin, ifosfamide and dacarbazine) chemotherapy. (20926411)
2011
21
An early event of EGFR mutation in pleomorphic carcinoma of the lung. (21556797)
2011
22
EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy. (21409490)
2011
23
Pleomorphic carcinoma of the lung with intrapulmonary aerogenic metastases on FDG PET. (20706051)
2010
24
Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis. (20107421)
2010
25
Pleomorphic carcinoma of the breast in a 17-year-old woman. (20340005)
2010
26
Three cases of resected pleomorphic carcinoma. (21057444)
2010
27
The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma. (18989796)
2009
28
Esophageal polypoidal mass: presentation of an uncommon pleomorphic carcinoma. (19750865)
2009
29
Pleomorphic carcinoma of the lung with uncommon initial manifestation of intestinal perforation]. (19601528)
2009
30
Two cases of pleomorphic carcinoma with severe systemic inflammation]. (19764522)
2009
31
Pulmonary pleomorphic carcinoma mimicking bronchopneumonia in an elderly man. (23168472)
2009
32
Adult jejunojejunal intussusception caused by metastasized pleomorphic carcinoma of the lung: report of a case. (19882322)
2009
33
F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma. (18645378)
2008
34
Long-term survival in two cases of resected gastric metastasis of pulmonary pleomorphic carcinoma. (18594328)
2008
35
Palliative chemotherapy for pulmonary pleomorphic carcinoma. (17574296)
2007
36
Pulmonary pleomorphic carcinoma producing hCG. (17803660)
2007
37
Pleomorphic carcinoma of the lung rapidly developed multiple metastases after surgery]. (16715890)
2006
38
Expression of caveolin-1 in pleomorphic carcinoma of the lung is correlated with a poor prognosis. (16334154)
2005
39
Resection of a pleomorphic carcinoma of the lung invading the descending aorta. (15173751)
2004
40
K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung. (14990969)
2004
41
Pleomorphic carcinoma of the breast: clinicopathological analysis of 26 cases of an unusual high-grade phenotype of ductal carcinoma. (10849092)
2000
42
Pleomorphic carcinoma of the pancreas with massive lymphocytic stromal infiltration and long-term survival after resection. (10952407)
2000
43
Pleomorphic carcinoma (spindle and giant cell) of the lung. (7968314)
1994
44
Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells. (8113629)
1993
45
Surgical treatment of pleomorphic carcinoma of the pancreas. (2190511)
1990
46
Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells expressing an epithelial-associated antigen detected by monoclonal antibody 44-3A6. (3254809)
1988
47
Pleomorphic carcinoma of the pancreas: computed-tomographic, sonographic, and pathologic findings. (3880902)
1985
48
Pleomorphic carcinoma of the gallbladder: case report and ultrastructural study. (6539521)
1984
49
Pleomorphic carcinoma of the pancreas: an analysis of 15 cases. (870168)
1977
50
Unusual pleomorphic carcinoma of the pancreas featuring production of osteoid. (5252233)
1969

Variations for Pleomorphic Carcinoma

About this section

Expression for genes affiliated with Pleomorphic Carcinoma

About this section
Search GEO for disease gene expression data for Pleomorphic Carcinoma.

Pathways for genes affiliated with Pleomorphic Carcinoma

About this section

GO Terms for genes affiliated with Pleomorphic Carcinoma

About this section

Cellular components related to Pleomorphic Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1keratin filamentGO:00450959.0KRT14, KRT18, KRT8
2cell peripheryGO:00719449.0KRT14, KRT18, KRT8
3intermediate filamentGO:00058828.7KRT14, KRT18, KRT8

Biological processes related to Pleomorphic Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cerebral cortex cell migrationGO:002179510.0EGFR, NKX2-1
2extrinsic apoptotic signaling pathwayGO:00971919.9KRT18, KRT8
3hepatocyte apoptotic processGO:00972849.4KRT18, KRT8
4positive regulation of gene expressionGO:00106289.1KIT, NKX2-1, TP53

Molecular functions related to Pleomorphic Carcinoma according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1receptor signaling protein tyrosine kinase activityGO:00047169.8EGFR, KIT
2scaffold protein bindingGO:00971109.5KRT18, KRT8
3transmembrane receptor protein tyrosine kinase activityGO:00047149.4EGFR, KIT

Sources for Pleomorphic Carcinoma

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
25GTR
26HGMD
27HMDB
28ICD10
29ICD10 via Orphanet
30ICD9CM
31IUPHAR
32KEGG
35MedGen
37MeSH
38MESH via Orphanet
39MGI
42NCI
43NCIt
44NDF-RT
47NINDS
48Novoseek
50OMIM
51OMIM via Orphanet
55PubMed
56QIAGEN
61SNOMED-CT via Orphanet
65Tumor Gene Family of Databases
66UMLS
67UMLS via Orphanet